Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

KRMD Stock Forecast, Price Targets, Chart, Dividends & Analysis

Repro Med Systems Inc. logo

Repro Med Systems Inc.

Sector: Manufacturing   

Industry: Surgical and Medical Instrument Manufacturing

4.02
 
USD
  
0.32
  
(8.65%)
Previous close: 3.7  Open: 3.69  Bid: 3.45  Ask: 4.75
52 week range    
1.98   
   4.60
Mkt Cap: 189 M  Avg Vol (90 Days): 101,898
Peers   
NUVA / 
NVCN-CA / 
NURO / 
Last updated: Sunday 22nd December 2024

Stock Rankings

50
MarketXLS Rank
40
Value
76
Technical
36
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

NUMD

NURO

0 B-13.9

NUVA

39.75

NVCN-CA

Financials

KRMD Income Statement

Annual
Feb-13Feb-14Feb-16Feb-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles58722.059842.061787.064242.0
Basic EPS from continuing operations-0.03-0.1-0.19-0.3
Basic EPS total0.020.020.02-0.010.020.01-0.03-0.1-0.19-0.3
Basic weighted shares outstanding36 M37 M38 M38 M38 M39 M42 M44 M45 M46 M
Cost of sales-3 M-3 M-5 M-5 M-7 M-8 M9 M10 M13 M12 M
Depreciation190971.0232959.0271566.0300611.0309263.0340229.0418595.0463130.0587137.0870390.0
Depreciation unreconciled190971.0232959.0271566.0300611.0309263.0340229.0418595.0463130.0587137.0870390.0
DepreciationAndAmortization190971.0232959.0271566.0300611.0309263.0340229.0418595.0463130.0587137.0870390.0
Diluted EPS total0.020.020.02-0.010.020.01-0.03-0.1-0.19-0.3
Diluted normalized net income/share-0.03-0.1-0.19-0.3
Diluted weighted shares outstanding36 M37 M38 M38 M39 M39 M42 M44 M45 M46 M
GainOnSaleOfPPE4930.047830.016591.01009.0-59807.0
GeneralAndAdministrativeExpense-132504.0-132504.0-132504.0-170956.012 M18 M21 M20 M
Gross operating profit5 M5 M8 M8 M11 M15 M15 M14 M15 M17 M
Income before tax1 M1 M1 M-776699.01 M696418.01 M-6 M-11 M-10 M
Income taxes312347.0307024.0359706.0-241700.0266380.0132069.0-17800.0-2 M-2 M4 M
InterestExpenseNonOperating28280.04547.03412.01886.0-239.0237.060.05393.025343.0
MiscOtherSpecialCharges-9198.02937.028104.080663.042395.0692990.0145587.0561328.0
Net income from total operations725763.0703429.0782864.0-534999.0910570.0564349.0-1 M-5 M-9 M-14 M
NetIncomeCommonStockholders725763.0703429.0782864.0-534999.0910570.0564349.0-1 M-5 M-9 M-14 M
NetIncomeContinuousOperations725763.0703429.0782864.0-534999.0910570.0564349.0-1 M-5 M-9 M-14 M
NetNonOperatingInterestIncomeExpense-20199.02879.0-3412.0-1886.0239.0-237.0-60.0-145587.0-561328.0
NonRecurringOperationExpense899003.03 M2 M
Normalized income-8 M-8 M
Operating income1 M1 M1 M-736251.02 M4 M-1 M-7 M-11 M-10 M
Operating income before depreciation (EBITDA)1 M1 M1 M-446202.01 M1 M2 M-7 M-10 M-9 M
OperatingExpense4 M-4 M-6 M-8 M-10 M-14 M16 M21 M26 M27 M
Other income net9198.0-2937.0-33034.0-128493.0-58986.0-693999.0-39874.0-64931.0
OtherGandA-132504.0-132504.0-132504.0-170956.012 M18 M21 M20 M
OtherOperatingExpenses-149594.0216913.0296080.0645784.0579113.0
RentAndLandingFees-132504.0-132504.0-132504.0
Research & development expense147576.0218150.0207282.0237486.0241124.0740475.01 M2 M5 M6 M
ResearchExpense147576.0218150.0207282.0237486.0241124.0740475.01 M2 M5 M6 M
Revenue per share-80100.0-131850.0-4837.05302.02586.050895.0174808.0
SalariesAndWages-131850.03 M3 M
Selling Gen & administrative expense4 M4 M6 M8 M8 M10 M12 M18 M21 M20 M
SellingAndMarketingExpense4 M4 M6 M8 M8 M10 M
SellingExpense4 M4 M6 M8 M8 M10 M
Special income/charges-899003.0-3 M-2 M
Total Income available for interest expense (EBIT)1 M1 M1 M-774813.01 M696179.01 M-7 M-11 M-10 M
Total common shares outstanding37 M37 M38 M38 M38 M40 M44 M45 M46 M46 M
Total net income725763.0703429.0782864.0-534999.0910570.0564349.0-1 M-5 M-9 M-14 M
Total ordinary shares46 M46 M46 M46 M46 M46 M46 M46 M46 M46 M
Total revenues8 M9 M12 M12 M17 M23 M24 M23 M28 M29 M
TotalExpenses1 M-8 M-11 M-13 M-16 M-23 M25 M31 M39 M39 M
TotalRevenue8 M9 M12 M12 M17 M23 M24 M23 M28 M29 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University